Bio-Techne (TECH) Interest Coverage Ratio: History & Chart

Bio-Techne Corporation(TECH)

Biotechnology · Minneapolis, MN

$72.61+0.04 (+0.06%)

Delayed quote: Sep 25, 2026, 4:00 PM EDT

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Minneapolis, MN

3,000 employees

www.bio-techne.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Kim Kelderman

View full financials

TECH Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

46.60x

INTEREST COVERAGE RATIO AVG TTM

5.68x

INTEREST COVERAGE RATIO AVG 3Y

18.66x

INTEREST COVERAGE RATIO AVG 5Y

21.01x

INTEREST COVERAGE RATIO AVG 10Y

16.31x

INTEREST COVERAGE RATIO AVG 15Y

N/A

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+720.84%

CURRENT VS 3Y AVG

+149.78%

CURRENT VS 5Y AVG

+121.78%

CURRENT VS 10Y AVG

+185.67%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

6.88x

median of 82 covered companies

CURRENT VS SECTOR MEDIAN

+576.83%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Bio-Techne Corporation (TECH)	$11.37B	46.60x	5.68x	18.66x	21.01x
DaVita Inc. (DVA)vs ›	$11.46B	3.66x	4.05x	3.97x	4.62x
Universal Health Services, Inc. (UHS)vs ›	$10.83B	12.68x	10.82x	8.80x	10.61x
The Cooper Companies, Inc. (COO)vs ›	$10.80B	6.83x	6.50x	6.73x	9.55x
Baxter International Inc. (BAX)vs ›	$12.08B	-1.06x	0.71x	2.65x	6.89x
Align Technology, Inc. (ALGN)vs ›	$10.51B	N/A	67.41x	66.08x	407.22x
Encompass Health Corporation (EHC)vs ›	$12.25B	8.55x	7.42x	7.61x	6.89x
Bio-Rad Laboratories, Inc. (BIO)vs ›	$10.26B	5.52x	5.51x	7.63x	62.06x
The Ensign Group, Inc. (ENSG)vs ›	$10.21B	53.24x	48.24x	40.33x	37.20x
Penumbra, Inc. (PEN)vs ›	$12.56B	144.35x	102.58x	62.73x	62.73x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Bio-Techne Corporation (TECH)

$11.37B

46.60x

5.68x

18.66x

21.01x

DaVita Inc. (DVA)vs ›

$11.46B

3.66x

4.05x

3.97x

4.62x

Universal Health Services, Inc. (UHS)vs ›

$10.83B

12.68x

10.82x

8.80x

10.61x

The Cooper Companies, Inc. (COO)vs ›

$10.80B

6.83x

6.50x

6.73x

9.55x

Baxter International Inc. (BAX)vs ›

$12.08B

-1.06x

0.71x

2.65x

6.89x

Align Technology, Inc. (ALGN)vs ›

$10.51B

N/A

67.41x

66.08x

407.22x

Encompass Health Corporation (EHC)vs ›

$12.25B

8.55x

7.42x

7.61x

6.89x

Bio-Rad Laboratories, Inc. (BIO)vs ›

$10.26B

5.52x

5.51x

7.63x

62.06x

The Ensign Group, Inc. (ENSG)vs ›

$10.21B

53.24x

48.24x

40.33x

37.20x

Penumbra, Inc. (PEN)vs ›

$12.56B

144.35x

102.58x

62.73x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Bio-Techne Corporation (TECH)?

The interest coverage ratio for TECH stock is 46.60x.

Is Bio-Techne Corporation's interest coverage ratio high or low?

The interest coverage ratio of 46.60x is 122% above its 5-year average of 21.01x, near the high end of its 5-year range (-25.42x–58.68x).

What is the TTM average interest coverage ratio for Bio-Techne Corporation (TECH)?

The TTM average interest coverage ratio for TECH stock is 5.68x.

What is the 3Y average interest coverage ratio for Bio-Techne Corporation (TECH)?

The 3Y average interest coverage ratio for TECH stock is 18.66x.

What is the 5Y average interest coverage ratio for Bio-Techne Corporation (TECH)?

The 5Y average interest coverage ratio for TECH stock is 21.01x.

What is the 10Y average interest coverage ratio for Bio-Techne Corporation (TECH)?

The 10Y average interest coverage ratio for TECH stock is 16.31x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	-25.42x
2026-03-31	23.43x
2025-12-31	25.09x
2025-09-30	16.24x
2025-06-30	-10.96x
2025-03-31	19.29x
2024-12-31	22.08x
2024-09-30	18.38x
2024-06-30	18.26x
2024-03-31	16.73x
2023-12-31	8.78x
2023-09-30	11.42x
2023-06-30	25.53x
2023-03-31	58.68x
2022-12-31	28.82x
2022-09-30	14.86x
2022-06-30	32.16x
2022-03-31	36.28x
2021-12-31	21.48x
2021-09-30	18.55x
2021-06-30	20.84x
2021-03-31	25.80x
2020-12-31	14.22x
2020-09-30	11.12x
2020-06-30	8.51x
2020-03-31	10.65x
2019-12-31	7.59x
2019-09-30	6.38x
2019-06-30	7.73x
2019-03-31	8.62x
2018-12-31	5.83x
2018-09-30	4.92x
2018-06-30	14.06x
2018-03-31	16.83x
2017-12-31	10.36x
2017-09-30	11.61x
2017-06-30	19.20x
2017-03-31	15.32x
2016-12-31	8.40x
2016-09-30	18.17x
2016-06-30	92.41x
2016-03-31	97.16x
2015-12-31	90.06x
2015-09-30	68.80x
2015-06-30	97.43x
2015-03-31	95.23x
2014-12-31	79.13x
2014-09-30	113.23x

DATE

INTEREST COVERAGE RATIO

2026-06-30

-25.42x

2026-03-31

23.43x

2025-12-31

25.09x

2025-09-30

16.24x

2025-06-30

-10.96x

2025-03-31

19.29x

2024-12-31

22.08x

2024-09-30

18.38x

2024-06-30

18.26x

2024-03-31

16.73x

2023-12-31

8.78x

2023-09-30

11.42x

2023-06-30

25.53x

2023-03-31

58.68x

2022-12-31

28.82x

2022-09-30

14.86x

2022-06-30

32.16x

2022-03-31

36.28x

2021-12-31

21.48x

2021-09-30

18.55x

2021-06-30

20.84x

2021-03-31

25.80x

2020-12-31

14.22x

2020-09-30

11.12x

2020-06-30

8.51x

2020-03-31

10.65x

2019-12-31

7.59x

2019-09-30

6.38x

2019-06-30

7.73x

2019-03-31

8.62x

2018-12-31

5.83x

2018-09-30

4.92x

2018-06-30

14.06x

2018-03-31

16.83x

2017-12-31

10.36x

2017-09-30

11.61x

2017-06-30

19.20x

2017-03-31

15.32x

2016-12-31

8.40x

2016-09-30

18.17x

2016-06-30

92.41x

2016-03-31

97.16x

2015-12-31

90.06x

2015-09-30

68.80x

2015-06-30

97.43x

2015-03-31

95.23x

2014-12-31

79.13x

2014-09-30

113.23x

Interest Coverage Ratio: 46.60x

TECH Interest Coverage Ratio

TECH Average Interest Coverage Ratio Chart

TECH Current vs Average Interest Coverage Ratio Chart

TECH Interest Coverage Ratio Metrics

TECH Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

TECH Interest Coverage Ratio History

Related Metrics